Nutex Health (Nutex Health) ROCE %

: -28.15% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nutex Health's annualized ROCE % for the quarter that ended in Dec. 2023 was -28.15%.

Nutex Health ROCE % Historical Data

The historical data trend for Nutex Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nutex Health Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

33.26

79.22

55.42

-110.97

-8.98

Nutex Health Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial										-6.24	-4.95	-0.25	-0.78	-28.15

Nutex Health ROCE % Calculation

Nutex Health's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-32.173	/	( ( (431.752 - 54.863)	+	(398.245 - 58.313) )	/ 2 )
	=	-32.173	/	( (376.889	+	339.932)	/ 2 )
	=	-32.173	/	358.4105
	=	-8.98 %

Nutex Health's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-105.892	/	( ( (479.634 - 67.267)	+	(398.245 - 58.313) )	/ 2 )
	=	-105.892	/	( ( 412.367	+	339.932 )	/ 2 )
	=	-105.892	/	376.1495
	=	-28.15 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Nutex Health (NAS:NUTX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nutex Health ROCE % Related Terms

Thank you for viewing the detailed overview of Nutex Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nutex Health (Nutex Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nutex Health Inc (NAS:NUTX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6030 S. Rice Ave, Suite C, Houston, TX, USA, 77081

Website

https://www.nutexhealth.com

Nutex Health Inc is healthcare services and operations company with 19 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

Executives

Thomas T. Vo	director, officer: Chairman, CEO	6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Joshua Detillio	officer: Chief Operating Officer	6030 S. RICE AVENUE, SUITE C, HOUSTON TX 77081
Jon Christian Bates	officer: Chief Financial Officer	6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Mitchell Creem	director	700 NORTH BRAND BLVD., SUITE 450, GLENDALE CA 91203
Pamela W. Montgomery	officer: Chief Legal Off. & Secretary	6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Michael Lee Reed	director	6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Cheryl Yvonne Grenas	director	6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
John J Waters	director	2165 TECHNOLOGY DRIVE, SCHENECTADY NY 12308
Danniel Stites	director	3050 S. DOBSON ROAD, CHANDLER AZ 85248
Premier Macy Management Holdings, Llc	10 percent owner	2819 CYPRESS DRIVE, TEXARKANA TX 75503
Michael Bowen	officer: Chief Financial Officer	501 1ST AVENUE NORTH, SUITE 901, ST. PETERSBURG FL 33701
Warren Hosseinion	director	C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
Lawrence Schimmel	officer: Chief Medical Information Off	5193 SW 75TH STREET, MIAMI FL 33143
Frederick Sternberg	officer: President of subsidiary	10772 SANDY RUN RD, JUPTIER FL 33478
Micro Hospital Holding Llc	10 percent owner	6030 S. RICE AVE., SUITE C, HOUSTON TX 77081